In vitro toxicity evaluation of graphene oxide on human RPMI 8226 cells

Biomed Mater Eng. 2014;24(6):2007-13. doi: 10.3233/BME-141010.

Abstract

This study had investigated the possible toxicity of graphene oxide and its mechanisms on multiple myeloma cells (RPMI 8226 cells) using flow cytometry and a multifunctional microplate reader. RPMI 8226 cells were cultured with various concentrations of graphene oxide, then cell viability, malondialdehyde, glutathione and apoptosis were measured. We found that graphene oxide dose-dependently reduced the viability of human multiple myeloma RPMI 8226 cells. We also found that the intracellular levels of malondialdehyde increased, whereas the levels of glutathione decreased dose-dependently. There was no obvious change in the cell apoptosis rate compared with the control group. In summary, graphene oxide is dose-dependently cytotoxic to cultured RPMI 8226 cells, and its toxicity is closely associated with increased oxidative stress.

Keywords: Graphene oxide; RPMI 8226 cells; cytotoxicity; oxidative stress.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / drug effects
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Dose-Response Relationship, Drug
  • Graphite / administration & dosage*
  • Humans
  • Multiple Myeloma / drug therapy*
  • Multiple Myeloma / pathology*
  • Oxides / administration & dosage*
  • Treatment Outcome

Substances

  • Oxides
  • Graphite